CompletedNCT00265343
This study is completed. It focuses on schizophrenia and currently lists study information in Global.
SchizophreniaOtherOver 18 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Schizophrenia
CompletedNCT00174265
This study is completed in Global. It focuses on Schizophrenia.
SchizophreniaOtherOver 18 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Schizophrenia
CompletedNCT01098110
This study is completed in Global. It is testing asenapine Compared to Placebo for schizophrenia.
SchizophreniaOtherFrom 20 Years to 64 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Schizophrenia
CompletedNCT05486312
This study is completed. It focuses on schizophrenia and currently lists study information in the United States.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- Click Therapeutics, Inc.
- Condition
- Schizophrenia
CompletedNCT04235686
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
Bipolarity, DepressionOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Mayo Clinic
- Condition
- Bipolarity, Depression
CompletedNCT00143182
This study is completed. It focuses on bipolarity and currently lists study information in Global.
BipolarityOtherOver 18 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Bipolarity
TerminatedNCT04742413
This study has public registry information in Spain. It focuses on schizophrenia.
SchizophreniaOtherOver 18 Years
- Countries
- Spain
- Sponsor
- Angelini Farmacéutica
- Condition
- Schizophrenia
CompletedNCT03379597
This study is completed in China. It is testing dietary Fiber and Probiotics Treatment for schizophrenia.
Bipolarity, SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- China
- Sponsor
- Central South University
- Condition
- Bipolarity, Schizophrenia
CompletedNCT03785223
This study is completed in Canada. It is testing methylphenidate Hydrochloride Controlled Release Capsules for ADHD.
Anxiety, ADHDOtherFrom 18 Years to 65 Years
- Countries
- Canada
- Sponsor
- McMaster University
- Condition
- Anxiety, ADHD
OngoingEUCTR 2022-002757-26
This study is ongoing in Lithuania, in Slovakia, in Bulgaria, .... It focuses on Depression.
DepressionOther
- Countries
- Lithuania, Slovakia, Bulgaria, ...
- Sponsor
- HMNC Holding GmbH
- Condition
- Depression
OngoingEUCTR 2018-003252-20
This study is ongoing in the United Kingdom, in Slovakia, in Poland, .... It is testing pimavanserin for depression.
DepressionOther
- Countries
- United Kingdom, Slovakia, Poland, ...
- Sponsor
- ACADIA Pharmaceuticals Inc
- Condition
- Depression
TerminatedEUCTR 2016-003435-38
This study has public registry information in Hungary, in Spain, in Bulgaria, .... It is testing pimavanserin for schizophrenia.
SchizophreniaOther
- Countries
- Hungary, Spain, Bulgaria, ...
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
